Ignite Creation Date:
2025-12-25 @ 12:36 AM
Ignite Modification Date:
2026-05-04 @ 4:19 PM
Study NCT ID:
NCT03222167
Status:
UNKNOWN
Last Update Posted:
2017-08-07
First Post:
2017-07-17
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Open-Label Efficacy and Safety Study of the Elbasvir/ Grazoprevir Fixed Dose Combination Patients With Chronic HCV GT1b
Sponsor:
Institute Of Cardiology & Internal Diseases, Kazakhstan
Organization:
Organization Data
Organization:
Class:
OTHER_GOV
Study ID:
ICID.HCV.0117
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER_GOV
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None